8 completed. 8 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 3 | 1 | Completed 1 |
Follow Ileus: new trials by email Literature Review of Ileus trials Research Report on Ileus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection LB1148, Placebo - Ileus, Post-Operative Adhesions | Phase 2 | Completed | Palisade Bio | 112 | 2019-10-01 | 2024-06-21 |
| Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus LB1148, Placebo - Ileus | Phase 2 | Completed | Newsoara Biopharma Co., Ltd. | 131 | 2019-07-09 | 2021-09-27 |
| Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention Methylnaltrexone, Placebo - Postoperative Ileus | Phase 2 | Completed | Ohio State University | 82 | 2019-02-21 | 2021-10-27 |
| The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection Foeniculum Vulgare Seed Ironing - Colorectal Surgery, Foeniculum | Phase 2 | Completed | West China Hospital | 300 | 2018-10-20 | 2019-09-17 |
| The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section Gum chewing - Paralytic Ileus | Phase 2 / Phase 3 | Completed | Chiang Mai University | 100 | 2010-05-01 | 2011-06-28 |
| Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea Eluxadoline, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 807 | 2010-04-28 | 2019-10-22 |
| Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus Ipamorelin, placebo - Ileus | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 117 | 2008-04-01 | 2017-04-14 |
| A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 146 | 2007-10-01 | 2019-03-19 |
Abdominal Abscess (1) · Bacterial Infections (1) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Colonic Pseudo-Obstruction (1) · Diarrhea (1) · Digestive System Diseases (1) · Fever (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Intestinal Pseudo-Obstruction (1) · Irritable Bowel Syndrome (1) · Pneumonia (1) · Pneumonia, Bacterial (1)
Intestinal Obstruction (8) · Digestive System Diseases (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (7) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Abscess (1) · Bacterial Infections and Mycoses (1) · Body Temperature Changes (1) · Cross Infection (1) · Disease Attributes (1) · Healthcare-Associated Pneumonia (1) · Iatrogenic Disease (1) · Infections (1)
Chewing Gum (1) · Cilastatin, Imipenem Drug Combination (1) · Doripenem (1) · Exercise (1) · eluxadoline (1) · ipamorelin (1) · methylnaltrexone (1)
Chiang Mai University (1) · Furiex Pharmaceuticals, Inc (1) · Helsinn Therapeutics (U.S.), Inc (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Newsoara Biopharma Co., Ltd. (1) · Ohio State University (1) · Palisade Bio (1) · West China Hospital (1)
United States (4) · China (2) · Thailand (1)
Kittipat Charoenkwan, MD (1) · Mitch Jones, MD (1) · Suzan Allen (1) · Ziqiang Wang, MD (1)
PMID 15351109, PMID 16850151, PMID 19610681, PMID 20334152, PMID 23583433, PMID 24813429, PMID 25331030, PMID 25819420, PMID 26867333, PMID 28167156, PMID 29067571, PMID 29621360, PMID 34798295